Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
BeiGene, Ltd. - American Depositary Shares
(NQ:
ONC
)
252.02
+2.18 (+0.87%)
Streaming Delayed Price
Updated: 1:59 PM EDT, Mar 13, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
120,182
Open
250.00
Bid (Size)
251.76 (1)
Ask (Size)
252.36 (1)
Prev. Close
249.84
Today's Range
246.89 - 253.16
52wk Range
172.67 - 287.88
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Earnings Scheduled For March 7, 2025
March 07, 2025
Via
Benzinga
China-Based Biotech BeiGene Scores FDA Approval For Tevimbra/Chemo Combo For Untreated Patients With Esophageal Cancer
March 04, 2025
BeiGene's Tevimbra wins FDA approval for first-line metastatic ESCC treatment, showing significant survival benefits in PD-L1-positive patients.
Via
Benzinga
Exposures
Product Safety
Performance
YTD
+36.97%
+36.97%
1 Month
+14.73%
+14.73%
3 Month
+36.97%
+36.97%
6 Month
+36.97%
+36.97%
1 Year
+36.97%
+36.97%
More News
Read More
TEVIMBRA Approved in U.S. for First-line Treatment of Advanced Esophageal Squamous Cell Carcinoma in Combination with Chemotherapy
March 04, 2025
From
BeiGene, Ltd.
Via
Business Wire
BeiGene Announces Fourth Quarter and Full Year 2024 Financial Results and Business Updates
February 27, 2025
From
BeiGene, Ltd.
Via
Business Wire
Earnings Scheduled For February 27, 2025
February 27, 2025
Via
Benzinga
BeiGene to Present at Upcoming Investor Conferences
February 25, 2025
From
BeiGene
Via
Business Wire
Alibaba, Super Micro Computer And XPeng Are Among Top 10 Large Cap Gainers Last Week (Feb 17-Feb 21): Are The Others In Your Portfolio?
February 23, 2025
Via
Benzinga
BeiGene to Announce Fourth Quarter and Full Year 2024 Financial Results on February 27
February 13, 2025
From
BeiGene, Ltd.
Via
Business Wire
ImmunityBio Stock Soars On BeiGene Tie-Up, Supply Deal: Retail Gets Dose Of Optimism
January 29, 2025
Via
Stocktwits
Leap Therapeutics Halts Sirexatamab Combo Therapy For Gastric Cancer ON Unclear Positive Signal, Stock Crashes
January 28, 2025
Via
Benzinga
MicroStrategy, SoFi Technologies And Carvana Are Among Top Large-Cap Gainers Last Week (Jan 13-Jan 17): Are The Others In Your Portfolio?
January 19, 2025
Via
Benzinga
BeiGene Stock Meets 80-Plus RS Rating Benchmark
January 15, 2025
Via
Investor's Business Daily
10 Health Care Stocks With Whale Alerts In Today's Session
January 14, 2025
Via
Benzinga
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.